Raymond James & Associates Mannkind Corp Call Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MNKD
# of Institutions
260Shares Held
161MCall Options Held
1.99MPut Options Held
1.09M-
Black Rock Inc. New York, NY22.6MShares$125 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$89.1 Million0.0% of portfolio
-
State Street Corp Boston, MA9.95MShares$55.2 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$48.6 Million0.82% of portfolio
-
Nitorum Capital, L.P. New York, NY8.75MShares$48.5 Million8.23% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.43B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...